Patent number: 6864261
Abstract: A compound of formula (wherein A, R1, R2, R6, m and n are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Piperazine Compound”); pharmaceutical compositions comprising a Piperazine Compound; and methods for treating pain, urinary incontinence (UI), an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis (ALS), dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia and depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperazine Compound are disclosed.
Type:
Grant
Filed:
May 2, 2003
Date of Patent:
March 8, 2005
Assignee:
Euro-Celtique S.A.
Inventors:
Parviz Gharagozloo, Khondaker Islam, Donald J. Kyle, Qun Sun, Laykea Tafesse, John William Frank Whitehead, Ji Yang, Xiaoming Zhou
